Open AccessExperience of using a genetically engineered biological drug biosimilar in patients with rheumatoid arthritis in real clinical practice
Author(s) -
E. Zhilyaev,
E. Koltsova,
Е. Шмидт,
K. Lytkina,
G. Lukina
Publication year - 2020
Publication title -
rmž. medicinskoe obozrenie
Language(s) - English
Resource type - Journals
eISSN - 2686-9918
pISSN - 2587-6821
DOI - 10.32364/2587-6821-2020-4-8-492-497
Subject(s) - biosimilar , medicine , rituximab , rheumatoid arthritis , erythrocyte sedimentation rate , adverse effect , regimen , rheumatoid factor , physical therapy , oncology , lymphoma